Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer

Medical Oncology

Volumn 28, Issue 3, 2011, Pages 789-795

  Yang, Xue Qin ^a,b   Li, Yan ^a   Chen, Chuang ^a   Peng, Chun Wei ^a   Liu, Shao Ping ^a   Liu, Yang ^a  

^a WUHAN UNIVERSITY   (China)

^b JINGCHU UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Carbohydrate antigen 125; Carbohydrate antigen 19 9; Carcinoembryonic antigen; Colorectal cancer; Overall survival

Indexed keywords

CA 19-9 ANTIGEN; CARBOHYDRATE ANTIGEN; CARBOHYDRATE ANTIGEN 125; CARCINOEMBRYONIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PREOPERATIVE PERIOD; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80052458606     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9518-z     Document Type: Article

References (22)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 2 74 108 15761078 10.3322/canjclin.55.2.74
2. S Zheng 2006 Prevention of colorectal carcinoma Chin J Cancer Prev Treat 13 1 1 2
3. Ministery of Health of the People's Republic Of China. Mortality rate of 10 main malignant neoplasms from 2004 to 2005. http://www.moh.gov.cn/ publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2009/t-9.htm.
4. XQ Yang L Yan C Chen JX Hou Y Li 2009 Application of C12 multi-tumor marker protein chip in the diagnosis of gastrointestinal cancer: results of 329 surgical patients and suggestions for improvement Hepatogastroenterol 56 94-95 1388 1394 1:CAS:528:DC%2BD1MXhsFWlu7nN
5. R Tang CY Yeh JY Wang CR Changchien JS Chen LL Hsieh 2009 Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection Ann Surg Oncol 16 9 2516 2523 19565285 10.1245/s10434-009-0578-2
6. LC Sun KS Chu SC Cheng CY Lu CH Kuo JS Hsieh YL Shih SJ Chang JY Wang 2009 Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment BMC Cancer 9 1 288 295 19691850 10.1186/1471-2407-9-288
7. MN Holten-Andersen C Fenger HJ Nielsen AS Rasmussen IJ Christensen N Brünner O Kronborg 2004 Plasma TIMP-1 in patients with colorectal adenomas: a prospective study Eur J Cancer 40 14 2159 2164 15341992 10.1016/j.ejca.2004. 06.011 1:CAS:528:DC%2BD2cXntlGhu7o%3D
8. M Holten-Andersen IJ Christensen M Nilbert PO Bendahl HJ Nielsen N Brünner E Fernebro 2004 Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival. A validation study Eur J Cancer 40 1 64 72 14687791 10.1016/j.ejca.2003.09.019 1:CAS:528:DC%2BD3sXpvVWht74%3D
9. B Mroczko M Groblewska U Wereszczyńska-Siemiatkowska B Okulczyk B Kedra W Łaszewicz A Dabrowski M Szmitkowski 2007 Serum macrophagecolony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis Clin Chim Acta 380 1-2 208 212 17368603 10.1016/j.cca.2007.02.037 1:CAS:528:DC%2BD2sXjslSlurY%3D
10. DG Rosen L Wang JN Atkinson Y Yu KH Lu EP Diamandis I Hellstrom SC Mok J Liu RC Bast Jr 2005 Potential markers that complement expression of CA125 in epithelial ovarian cancer Gynecol Oncol 99 2 267 277 16061277 10.1016/j.ygyno.2005.06.040 1:CAS:528:DC%2BD2MXhtFKhsrfM
11. AT Baron CH Boardman JM Lafky A Rademaker D Liu DA Fishman KC Podratz NJ Maihle 2005 Soluble epidermal growth factor receptor (SEG-FR) and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer Cancer Epidemiol Biomarkers Prev 14 2 306 318 15734951 10.1158/1055-9965.EPI-04- 0423 1:CAS:528:DC%2BD2MXhs1GhsrY%3D
12. C Miralles M Orea P España M Provencio A Sánchez B Cantos R Cubedo E Carcereny F Bonilla T Gea 2003 Cancer antigen 125 associated with multiple benign and malignant pathologies Ann Surg Oncol 10 2 150 154 12620910 10.1245/ASO.2003.05.015 1:STN:280:DC%2BD3s7gslOgtA%3D%3D
13. S Morita T Nomura Y Fukushima T Morimoto N Hiraoka N Shibata 2004 Does serum CA19-9 play a practical role in the management of patients with colorectal cancer? Dis Colon Rectum 47 2 227 232 15043294 10.1007/s10350-003-0041-6
14. IJ Papk GS Choi SH Jun 2009 Prognostic value of serum tumor antigen CA19-9 after curative resection of colorectal cancer Anticancer Res 29 10 4303 4308
15. IJ Park GS Choi KH Lim BM Kang SH Jun 2009 Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level Ann Surg Oncol 16 11 3087 3093 19629600 10.1245/s10434-009-0625-z
16. MJ Duffy 2001 Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 47 4 624 630 11274010 1:CAS:528: DC%2BD3MXis1Kjur0%3D
17. MJ Goldstein EP Mitchell 2005 Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer Cancer Invest 23 4 338 351 16100946
18. F Rodríguez-Moranta J Saló A Arcusa J Boadas V Piñol X Bessa E Batiste-Alentorn AM Lacy S Delgado J Maurel JM Piqué A Castells 2006 Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial J Clin Oncol 24 3 386 393 16365182 10.1200/JCO.2005.02.0826
19. JY Wang CH Wu CY Lu JS Hsieh DC Wu SY Huang SR Lin 2006 Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis World J Surg 30 6 1007 1013 16736329 10.1007/s00268-005-0485-z
20. PC Li LD Chen F Zheng Y Li 2008 Intraperitoneal chemotherapy with hydroxycamptothecin reduces peritoneal carcinomatosis: results of an experimental study J Cancer Res Clin Oncol 134 1 37 44 17665213 10.1007/s00432-007-0242-9 1:CAS:528:DC%2BD2sXht1KrurvO
21. HAH Al-Shammaa Y Li Y Yonemura 2008 Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis World J Gastroenterol 14 8 1159 1166 18300340 10.3748/wjg.14.1159
22. XJ Yang Y Li HAH Al-shammaa GL Yang SY Liu YL Lu JW Zhang Y Yonemura 2009 Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases Ann Surg Oncol 16 2 345 351 19018599 10.1245/s10434-008-0226-2